Evidence map›Paper›PMID 22592998›Full record

ReviewGlia2012

Astrocytic regulation of glutamate homeostasis in epilepsy.

Douglas A Coulter, Tore Eid

Open access · bronzeAbstract readReview
In one paragraph

Review in Glia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 1 synthesis or guideline pooled it, 293 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Therapeutic Efficacy ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Intertwined associations between oxytocin, immune system and major depressive disorder.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Douglas A CoulterDepartment of Pediatrics, University of Pennsylvania School of Medicine and the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA. coulterd@mail.med.upenn.edu
Tore Eid
University of Pennsylvania · USYale New Haven Hospital · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Neuronal Circuit Mechanisms of EpileptogenesisR01NS038572 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI COULTER, DOUGLAS A · 1999 to 2022
$8.0M
The Synthesis of GABA in Epileptic BrainP01NS054900 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI COULTER, DOUGLAS A · 2007 to 2011
$6.4M
ASTROCYTE/NEURON SIGNALINGR01NS037585 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI HAYDON, PHILIP G · 1998 to 2019
$4.5M
The Regulation of Protein Synthesis within Synaptically Associated AstrocytesP20MH071705 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI COULTER, DOUGLAS A · 2004 to 2007
$2.5M
Glutamine Synthetase and the Mechanism of Seizures in Mesial Temporal Lobe EpilepR01NS070824 · NINDS · YALE UNIVERSITY · PI EID, TORE · 2010 to 2014
$1.9M
Dysregulation of Glutamine Synthetase in Human Temporal Lobe EpilepsyK08NS058674 · NINDS · YALE UNIVERSITY · PI EID, TORE · 2008 to 2012
$867k
NCRR NIH HHS UL1 RR024139NIMH NIH HHS P20 MH071705NINDS NIH HHS K08 NS058674NINDS NIH HHS NS058674NINDS NIH HHS NS070824NINDS NIH HHS P01 NS054900NINDS NIH HHS R01 NS037585NINDS NIH HHS R01 NS038572NINDS NIH HHS R01 NS070824
6 · The paper itself

Abstract

Astrocytes play a critical role in regulation of extracellular neurotransmitter levels in the central nervous system. This function is particularly prominent for the excitatory amino acid glutamate, with estimates that 80-90% of extracellular glutamate uptake in brain is through astrocytic glutamate transporters. This uptake has significance both in regulation of the potential toxic accumulation of extracellular glutamate and in normal resupply of inhibitory and excitatory synapses with neurotransmitter. This resupply of neurotransmitter is accomplished by astroglial uptake of glutamate, transformation of glutamate to glutamine by the astrocytic enzyme glutamine synthetase (GS), and shuttling of glutamine back to excitatory and inhibitory neurons via specialized transporters. Once in neurons, glutamine is enzymatically converted back to glutamate, which is utilized for synaptic transmission, either directly, or following decarboxylation to γ-aminobutyric acid. Many neurologic and psychiatric conditions, particularly epilepsy, are accompanied by the development of reactive gliosis, a pathology characterized by anatomical and biochemical plasticity in astrocytes, accompanied by proliferation of these cells. Among the biochemical changes evident in reactive astrocytes is a downregulation of several of the important regulators of the glutamine-glutamate cycle, including GS, and possibly also glutamate transporters. This downregulation may have significance in contributing both to the aberrant excitability and to the altered neuropathology characterizing epilepsy. In the present review, we provide an overview of the normal function of astrocytes in regulating extracellular glutamate homeostasis, neurotransmitter supply, and excitotoxicity. We further discuss the potential role reactive gliosis may play in the pathophysiology of epilepsy.

Indexed as

HomeostasisAnimalsAstrocytesEpilepsyGlutamic AcidHumansGlutamic Acid

Identifiers

PMID22592998
PMCPMC3375386
OpenAlexW2068687319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.